Despite a haemophilia market bustling with rivals, Qfitlia’s broad label and favourable dosing regimen could give it an upper hand.

while thrombin formation from activated coagulation stimulates the activation of proinflammatory mediators. These mechanisms are impaired in sepsis. TNF-α causes impairment of the inhibitors of ...

Novo Nordisk also conducted an intra-patient analysis in people with prior coagulation factor prophylaxis. The analysis showed superior reductions of 48% and 43% in treated bleeds upon treatment ...

Hemophilia A and hemophilia B are genetic bleeding disorders caused by a dysfunction or deficiency of coagulation factor VIII (FVIII) or IX (FIX), respectively. Patients with these hemophilias are ...